ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed  with the New 2.2 Software Version and the Integrated Maestro Brain Model

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

4.9
(224)
Write Review
More
$ 7.00
Add to Cart
In stock
Description

Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint

ClearPoint Neuro, Inc. on LinkedIn: #neurosurgeons #clearpoint #clinicalspecialist #employeehighlight #clpt…

SNN

SNN

ClearPoint Neuro, Inc. Announces First-in-Human Cases of

Stock Market News 2024-02-21

SNN

ClearPoint Neuro, Inc. on LinkedIn: Doctors test experimental treatment to combat seizures in epilepsy patients

SNN

SNN

SNN